Published date: 27 February 2018

This notice was replaced on 16 July 2018

This notice does not contain the most up-to-date information about this procurement. The most recent notice is:

Awarded contract (published 16 July 2018)

Closed opportunity - This means that the contract is currently closed. The buying department may be considering suppliers that have already applied, or no suitable offers were made.


Contract summary

Industry

  • Pharmaceutical products - 33600000

Location of contract

Any region, Scotland, Wales, Northern Ireland

Value of contract

£18,000,000

Procurement reference

tender_164721/654373

Published date

27 February 2018

Closing date

29 March 2018

Contract start date

1 July 2018

Contract end date

30 June 2019

Contract type

Supply contract

Procedure type

Open procedure

Any interested supplier may submit a tender in response to an opportunity notice.

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

No

Description

NHS framework agreement for the supply of Icatibant and C1 Esterase products for the treatment of Hereditary Angioedema. The framework agreement is intended for use by the Department of Health and Social Care, Public Health England and the NHS in England, Scotland, Wales and Northern Ireland. The framework may also be used by private sector contractors and agents working on behalf of the above. The framework will commence on the 1.7.2018 for a period of 12 months until 30.6.2019, with options to extend up to a further 36 months.

More information

Attachments

About the buyer

Address

2nd Floor, Rutland House
Runcorn
WA7 2ES
England

Email

alison.greenwood3@nhs.net